Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 17/20 | 0.38 |
| ▸ | CA1 | P00915 | 16/20 | 0.38 |
| ▸ | CA9 | Q16790 | 14/20 | 0.38 |
| ▸ | CA12 | O43570 | 5/20 | 0.38 |
| ▸ | CA7 | P43166 | 5/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.38 |
| ▸ | CA3 | P07451 | 4/20 | 0.38 |
| ▸ | CA4 | P22748 | 4/20 | 0.38 |
| ▸ | CA6 | P23280 | 4/20 | 0.38 |
| ▸ | CA5A | P35218 | 4/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MMP9 | P14780 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15608435 | 0.91 | CA2 (0.40) | CA2CA1CA9CA12CA7 | |
| SCHEMBL8398329 | 0.89 | CA2 (0.46) | CA2CA1CA9CA12CA7 | |
| SCHEMBL4952312 | 0.89 | CA2 (0.46) | CA2CA1CA9CA12CA7 | |
| SCHEMBL23291930 | 0.89 | CA2 (0.46) | CA2CA1CA9CA12CA7 | |
| SCHEMBL14779178 | 0.89 | CA2 (0.46) | CA2CA1CA9CA12CA7 | |
| SCHEMBL2735589 | 0.89 | CA2 (0.46) | CA2CA1CA9CA12CA7 | |
| SCHEMBL575713 | 0.87 | CA2 (0.44) | CA2CA1CA9CA12CA7 | |
| SCHEMBL780399 | 0.82 | CA2 (0.42) | CA2CA1CA9 | |
| SCHEMBL576009 | 0.82 | CA2 (0.44) | CA2CA1CA9CA12CA7 | |
| SCHEMBL1744340 | 0.79 | CA1 (0.55) | CA2CA1CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220204444-A1 | METHOD OF MANUFACTURING FLUORINE-CONTAINING COMPOUND | AGC Inc. (JP) | 2022-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220204444-A1 | METHOD OF MANUFACTURING FLUORINE-CONTAINING COMPOUND | AFF2, AFF4, AFF1 | CA2 521/4885CA1 317/4885CA9 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.